Evidence map›Paper›PMID 36589902›Full record

ArticleEnvironmetrics2022

Continuous Model Averaging for Benchmark Dose Analysis: Averaging Over Distributional Forms.

Matthew W Wheeler, Jose Cortinas, Marc Aerts, Jeffery S Gift, J Allen Davis

Abstract read
In one paragraph

Article in Environmetrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Guidance on the use of the benchmark dose approach in risk assessment.EFSA journal. European Food Safety Authority · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matthew W WheelerBiostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, RTP, NC, USA.
Jose CortinasEuropean Food Safety Authority.
Marc AertsCenter for Statistics, Hasslet University.
Jeffery S GiftNational Center for Environmental Assessment,US Environmental Protection Agency, RTP, NC, USA.
J Allen DavisNational Center for Environmental Assessment, U.S. Environmental Protection Agency, Cincinnati, OH, USA.

Funding

Non-parametric Bayesian Method DevelopmentZIAES103357 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI WHEELER, MATTHEW · 2020 to 2024
$546k
Dose-response Methods Development for High Throughput, Nontraditional, and Standard BioassaysZIAES103358 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI WHEELER, MATTHEW · 2020 to 2024
$546k
Intramural NIH HHS Z99 ES999999Intramural NIH HHS ZIA ES103357Intramural NIH HHS ZIA ES103358
6 · The paper itself

Abstract

When estimating a benchmark dose (BMD) from chemical toxicity experiments, model averaging is recommended by the National Institute for Occupational Safety and Health, World Health Organization and European Food Safety Authority. Though numerous studies exist for Model Average BMD estimation using dichotomous responses, fewer studies investigate it for BMD estimation using continuous response. In this setting, model averaging a BMD poses additional problems as the assumed distribution is essential to many BMD definitions, and distributional uncertainty is underestimated when one error distribution is chosen a priori. As model averaging combines full models, there is no reason one cannot include multiple error distributions. Consequently, we define a continuous model averaging approach over distributional models and show that it is superior to single distribution model averaging. To show the superiority of the approach, we apply the method to simulated and experimental response data.

Indexed as

Bayes FactorsDistributional UncertaintyDose-Response AnalysisQuantitative Risk Analysis

Identifiers

PMID36589902
PMCPMC9799099

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.